Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients
Status:
Unknown status
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
This study is to investigate the efficacy and safety of Folfox4 chemotherapy regimen to
prevent early recurrence for hepatocellular carcinoma patients with portal vein tumor
thrombus following curative resection